- Home
- HOG vs NUVL Comparison
HOG vs NUVL Comparison
Compare HOG & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOG
- NUVL
- Stock Information
- Founded
- HOG 1903
- NUVL 2017
- Country
- HOG United States
- NUVL United States
- Employees
- HOG N/A
- NUVL N/A
- Industry
- HOG Motor Vehicles
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- HOG Consumer Discretionary
- NUVL Health Care
- Exchange
- HOG Nasdaq
- NUVL Nasdaq
- Market Cap
- HOG 4.2B
- NUVL 4.9B
- IPO Year
- HOG N/A
- NUVL 2021
- Fundamental
- Price
- HOG $33.53
- NUVL $94.93
- Analyst Decision
- HOG Buy
- NUVL Strong Buy
- Analyst Count
- HOG 7
- NUVL 10
- Target Price
- HOG $42.71
- NUVL $112.60
- AVG Volume (30 Days)
- HOG 1.5M
- NUVL 457.6K
- Earning Date
- HOG 10-24-2024
- NUVL 11-12-2024
- Dividend Yield
- HOG 2.06%
- NUVL N/A
- EPS Growth
- HOG N/A
- NUVL N/A
- EPS
- HOG 4.40
- NUVL N/A
- Revenue
- HOG $5,552,403,000.00
- NUVL N/A
- Revenue This Year
- HOG N/A
- NUVL N/A
- Revenue Next Year
- HOG $1.49
- NUVL N/A
- P/E Ratio
- HOG $7.62
- NUVL N/A
- Revenue Growth
- HOG N/A
- NUVL N/A
- 52 Week Low
- HOG $29.67
- NUVL $61.02
- 52 Week High
- HOG $44.16
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- HOG 52.02
- NUVL 54.20
- Support Level
- HOG $32.04
- NUVL $90.12
- Resistance Level
- HOG $33.53
- NUVL $96.24
- Average True Range (ATR)
- HOG 0.86
- NUVL 3.19
- MACD
- HOG 0.22
- NUVL 0.47
- Stochastic Oscillator
- HOG 76.47
- NUVL 86.66
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 38% of the heavyweight domestic market in 2023.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.